Relationship between mechanical properties and crystal structure in cocrystals and salt of paracetamol

References

• Sheth AR, Grant DJW. Relationship between the structure and properties of pharmaceutical crystals. Kona 2005;23:36–48.
   Web of Science ®Google Scholar
• Almarsson Ö, Zaworotko MJ. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem Commun 2004;17:1889–96.
   PubMed Web of Science ®Google Scholar
• Peterson ML, Hickey MB, Zaworotko MJ, Almarsson Ö. Expanding the scope of crystal form evaluation in pharmaceutical science. J Pharm Pharm Sci 2006;9:317–26.
   PubMed Web of Science ®Google Scholar
• Qiao N, Li M, Schlindwein W, et al. Pharmaceutical cocrystals: an overview. Int J Pharm 2011;419:1–11.
   PubMed Web of Science ®Google Scholar
• Steed JW. The role of co-crystals in pharmaceutical design. Trends Pharmacol Sci 2013;34:185–93.
   PubMed Web of Science ®Google Scholar
• Wu C, Ruddy OM, Bentham AC, et al. Modeling the mechanical behavior of pharmaceutical powders during compaction. Powder Technol 2005;152:107–17.
   Web of Science ®Google Scholar
• Sun CC. Materials science tetrahedron-a useful tool for pharmaceutical research and development. J Pharm Sci 2009;98:1671–87.
   PubMed Web of Science ®Google Scholar
• Jain S. Mechanical properties of powders for compaction and tableting: an overview. Pharm Sci Technol Today 1999;2:20–31.
   PubMedGoogle Scholar
• Chattoraj S, Shi L, Chen M, et al. Origin of deteriorated crystal plasticity and compaction properties of a 1:1 cocrystal between piroxicam and saccharin. Cryst Growth Des 2014;14:3864–74.
   Web of Science ®Google Scholar
• Duberg M, Nystroem C. Studies on direct compression of tablets. XVII. Porosity-pressure curves for the characterization of volume reduction mechanisms in powder compression. Powder Technol 1986;46:67–75.
   Web of Science ®Google Scholar
• Taylor LJ, Papadopoulos DG, Dunn PJ, et al. Predictive milling of pharmaceutical materials using nanoindentation of single crystals. Org Process Res Dev 2004;8:674–9.
   Web of Science ®Google Scholar
• Sun CC, Kiang Y. On the identification of slip planes in organic crystals based on attachment energy calculation. J Pharm Sci 2008;97:3456–61.
   PubMed Web of Science ®Google Scholar
• Chattoraj S, Shi L, Sun CC. Understanding the relationship between crystal structure, plasticity and compaction behavior of theophylline, methyl gallate, and their 1:1 co-crystal. CrystEngComm 2010;12:2466–72.
   Web of Science ®Google Scholar
• Martino PD, Guyot-Hermann A, Conflant P, et al. A new pure paracetamol for direct compression: the orthorhombic form. Int J Pharm 1996;128:1–8.
   Web of Science ®Google Scholar
• Basavoju S, Bostroem D, Velaga SP. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res 2008;25:530–41.
   PubMed Web of Science ®Google Scholar
• Shimpi MR, Childs SL, Bostroem D, Velaga SP. New cocrystals of ezetimibe with L-proline and imidazole. CrystEngComm 2014;16:8984–93.
   Web of Science ®Google Scholar
• Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des 2008;8:1575–9.
   Web of Science ®Google Scholar
• Nyqvist H. Saturated salt solutions for maintaining specified relative humidities. Int J Pharm Technol Prod Manuf 1983;4:47–8.
   Google Scholar
• Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci 1970;59:688–91.
   PubMed Web of Science ®Google Scholar
• Sun C. A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders. J Pharm Sci 2004;93:646–53.
   PubMed Web of Science ®Google Scholar
• Crystal-Impact B&P. Diamond-crystal and molecular structure visualization software. Bonn, Germany; 2008; 3.1f.
   Google Scholar
• Shariare MH, Leusen FJJ, de Matas M, et al. Prediction of the mechanical behavior of crystalline solids. Pharm Res 2012;29:319–31.
   PubMed Web of Science ®Google Scholar
• Maple JR, Hwang MJ, Stockfisch TP, et al. Derivation of class II force fields. I. Methodology and quantum force field for the alkyl function group and alkane molecules. J Comput Chem 1994;15:162–82.
   Web of Science ®Google Scholar
• Mayo SL, Olafson BD, Goddard WA. DREIDING: a generic force field for molecular simulations. J Phys Chem 1990;94:8897–909.
   Web of Science ®Google Scholar
• Docherty R, Clydesdale G, Roberts KJ, Bennema P. Application of Bravais-Friedel-Donnay-Harker, attachment energy and Ising models to predicting and understanding the morphology of molecular crystals. J Phys D Appl Phys 1991;24:89–99.
   Web of Science ®Google Scholar
• Aakeröy CB, Seddon KR. The hydrogen bond and crystal engineering. Chem Soc Rev 1993;22:397–407.
   Web of Science ®Google Scholar
• Bag PP, Chen M, Sun CC, Reddy CM. Direct correlation among crystal structure, mechanical behavior and tabletability in a trimorphic molecular compound. CrystEngComm 2012;14:3865–7.
   Web of Science ®Google Scholar
• Rodriguez-Hornedo N, Nehm SJ, Seefeldt KF, et al. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 2006;3:362–7.
   PubMed Web of Science ®Google Scholar
• Chiarella RA, Davey RJ, Peterson ML. Making co-crystals – the utility of ternary phase diagrams. Cryst Growth Des 2007;7:1223–6.
   Web of Science ®Google Scholar
• Childs SL, Rodriguez-Hornedo N, Reddy LS, et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. CrystEngComm 2008;10:856–64.
   Web of Science ®Google Scholar
• Alhalaweh A, George S, Bostroem D, Velaga SP. 1:1 and 2:1 urea-succinic acid cocrystals: structural diversity, solution chemistry, and thermodynamic stability. Cryst Growth Des 2010;10:4847–55.
   Web of Science ®Google Scholar
• Zhang GG, Henry RF, Borchardt TB, Lou X. Efficient co-crystal screening using solution-mediated phase transformation. J Pharm Sci 2007;96:990–5.
   PubMed Web of Science ®Google Scholar
• Gagniere E, Mangin D, Puel F, et al. Cocrystal formation in solution: in situ solute concentration monitoring of the two components and kinetic pathways. Cryst Growth Des 2009;9:3376–83.
   Web of Science ®Google Scholar
• Karki S, Friscic T, Fabian L, et al. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mater 2009;21:3905–39.
   Web of Science ®Google Scholar
• Perumalla SR, Shi L, Sun CC. Ionized form of acetaminophen with improved compaction properties. CrystEngComm 2012;14:2389–90.
   Web of Science ®Google Scholar
• Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008;25:781–91.
   PubMed Web of Science ®Google Scholar
• Sun C, Himmelspach MW. Reduced tabletability of roller compacted granules as a result of granule size enlargement. J Pharm Sci 2005;95:200–6.
   Web of Science ®Google Scholar
• Joiris E, Di Martino P, Berneron C, et al. Compression behavior of orthorhombic paracetamol. Pharm Res 1998;15:1122–30.
   PubMed Web of Science ®Google Scholar
• Rasenack N, Muller BW. Crystal habit and tableting behavior. Int J Pharm 2002;244:45–57.
   PubMed Web of Science ®Google Scholar
• Ryshkewitch E. Compression strength of porous sintered alumina and zirconia: 9th communication to ceramography. J Am Ceram Soc 1953;36:65–8.
   Web of Science ®Google Scholar
• Sun C, Grant DJW. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm Res 2001;18:274–80.
   PubMed Web of Science ®Google Scholar
• Sun CC. Cocrystallization for successful drug delivery. Expert Opin Drug Deliv 2013;10:201–13.
   PubMed Web of Science ®Google Scholar
• Thakuria R, Delori A, Jones W, et al. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm 2013;453:101–25.
   PubMed Web of Science ®Google Scholar
• Childs S, Chyall L, Dunlap J, et al. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. J Am Chem Soc 2004;126:13335–42.
   PubMed Web of Science ®Google Scholar
• Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007;59:617–30.
   PubMed Web of Science ®Google Scholar
• Cao X, Morganti M, Hancock BC, Masterson VM. Correlating particle hardness with powder compaction performance. J Pharm Sci 2010;99:4307–16.
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Khomane KS, Kumar L, Bansal AK. Relationship between crystal structure and mechanical properties of ranitidine hydrochloride polymorphs. CrystEngComm 2013;15:3959–64.
   Web of Science ®Google Scholar
• Khomane KS, Bansal AK. Weak hydrogen bonding interactions influence slip system activity and compaction behavior of pharmaceutical powders. J Pharm Sci 2013;102:4242–5.
   PubMed Web of Science ®Google Scholar
• Sun C, Grant DJW. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm Res 2004;21:382–6.
   PubMed Web of Science ®Google Scholar